Minerals Technologies Inc. develops, produces, and markets various mineral, mineral-based, and related systems and services. The company operates through two segments, Consumer & Specialties, and Engineered Solutions segments. The Consumer & Specialties segment offers household and personal care products, such as pet litter, personal care, fabric care, edible oil and renewable fluid purification, animal health, and agricultural products under the PREMIUM CHOICE, VitaLife, Sivocat, SIVO, RAFINOL, and ENERSOL brand names; and specialty additives products, including precipitated calcium carbonate and ground calcium carbonate products that are used in the paper, paperboard, and fiber-based packaging industries, as well as automotive, construction, consumer markets, and packaging applications. The Engineered Solutions segment provides high-temperature technology products consisting of custom-blended mineral and non-mineral products for casting auto and heavy truck parts, agriculture and construction equipment, municipal, infrastructure and other industrial castings; and environmental and infrastructure products comprising geosynthetic clay lining systems, vapor intrusion mitigation products, sub surface waterproofing systems, green roofs, wastewater remediation, drinking water purification technologies, and drilling products. In addition, this segment offers gunnable monolithic refractory products and application systems; monolithic refractory materials and pre-cast refractory shapes; refractory shapes and linings; carbon composites and pyrolitic graphite under PYROID brand; and filtration and well testing services. It markets its products primarily through its direct sales force, as well as regional distributors. The company operates in the United States, Canada, Latin America, Europe, Africa, and Asia. Minerals Technologies Inc. was incorporated in 1968 and is headquartered in New York, New York.

Minerals Technologies Inc.

Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Immatics today and set a price target of $23.00. Suvannavejh covers the Heal...

Immatics (IMTX) Receives a Buy from Mizuho Securities

Guggenheim analyst Paul Jeng reiterated a Buy rating on Immatics yesterday and set a price target of $16.00. The company’s shares closed yesterday ...

Guggenheim Keeps Their Buy Rating on Immatics (IMTX)

Immatics ( ($IMTX) ) has provided an update. On November 12, 2025, Immatics N.V. announced updated data from its Phase 1a trials for IMA402 PRAME B...

Immatics Reveals Promising Phase 1a Results for TCR Bispecifics

In a report released today, Chloe Lemaire from Jefferies maintained a Buy rating on MTU Aero Engines, with a price target of €500.00. The company’s...

MTU Aero Engines (0FC9) Receives a Rating Update from a Top Analyst

Kepler Capital analyst Aymeric Poulain maintained a Buy rating on MTU Aero Engines on October 28 and set a price target of €408.00. The company’s s...

Kepler Capital  Sticks to Their Buy Rating for MTU Aero Engines (0FC9)

UBS analyst Ian Douglas maintained a Hold rating on MTU Aero Engines today and set a price target of €390.00. The company’s shares closed yesterday...

UBS Keeps Their Hold Rating on MTU Aero Engines (0FC9)

Immatics ( ($IMTX) ) has shared an announcement. On October 27, 2025, Immatics N.V. announced the appointment of Amie Krause as Chief People Office...

Immatics Appoints Amie Krause as Chief People Officer Amidst Commercial Transition

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD – Research Report) and Im...

Analysts Are Bullish on These Healthcare Stocks: Revolution Medicines (RVMD), Immatics (IMTX)

In a report released on October 23, Aymeric Poulain from Kepler Capital maintained a Buy rating on MTU Aero Engines, with a price target of €400.00...

In a report released today, Pete Osterland from Truist Financial maintained a Buy rating on Minerals Technologies. The company’s shares closed yest...

Current Quarter	$1.29	Next Quarter	$1.36
Current Year	$5.54	Next Year	$6.38
QoQ Growth	+5.4%	YoY Growth	+15.2%
3Y EPS CAGR	+2.1%	Target Price	$82.00
Consensus	Buy	Upside	+39.5%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MTX	$58.79	+3.36%	169.82K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MTX	$58.79	+3.4%	169.82K
3
4
5
6

MTX

MTX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Minerals Technologies Inc. Data in Excel

Get Minerals Technologies Inc. Data in Excel